Value Partners Investments’s Eli Lilly LLY Stock Holding History

Value Partners Investments’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.56M	Sell	2,976 -41	-1%	-$41.9K	0.25%	38
2026 Q1	$2.77M	Buy	3,017 +160	+6%	+$162K	0.21%	49
2025 Q4	$3.07M	Sell	2,857 -382	-12%	-$365K	0.24%	45
2025 Q3	$2.47M	Buy	3,239 +15	+0.5%	+$11.2K	0.2%	54
2025 Q2	$2.51M	Buy	3,224 +313	+11%	+$243K	0.2%	58
2025 Q1	$2.41M	Buy	+2,911	New	+$2.42M	0.21%	51
2020 Q4	–	Sell	-29,896	Closed	-$4.43M	–	69
2020 Q3	$4.43M	Buy	29,896 +19,120	+177%	+$2.96M	0.45%	40
2020 Q2	$1.77M	Buy	+10,776	New	+$1.65M	0.18%	50

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Value Partners Investments's LLY Position: Q2 2026 in Review

Value Partners Investments reduced its Eli Lilly (LLY) stake by 1.4% in Q2 2026, selling an estimated $41.9K and leaving 2,976 shares worth $3.56M. The position accounts for 0.25% of the portfolio, ranked #38.

Value Partners Investments first reported a position in LLY in Q2 2020 and has held it in 8 quarters since. The position peaked at $4.43M in Q3 2020. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Value Partners Investments held 2,976 shares of Eli Lilly worth $3.56M as of Q2 2026.
Value Partners Investments sold 41 Eli Lilly shares in Q2 2026, an estimated $41.9K.
Eli Lilly made up 0.25% of Value Partners Investments's portfolio in Q2 2026, its #38 holding.
Value Partners Investments first reported a position in Eli Lilly in Q2 2020 and has held it in 8 quarters since.
Value Partners Investments's Eli Lilly position peaked at $4.43M in Q3 2020.
4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Value Partners Investments's 13F filing for Q2 2026, filed 15 Jul 2026.